Podravka stock holds growth as food and pharmaceuticals lead
Published on 11/05/2026 at 00:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPodravka's nine-month performance
- Food and pharmaceuticals supported Podravka Group growth through September 2026.
- Agriculture revenue declined as lower commodity prices and drought weighed on production.
- International demand helped the Lino Lada brand expand in Germany, Poland and the Czech Republic.
Podravka Group maintained revenue growth and high normalized profitability in the first nine months of 2026, according to a Podravka company release published on Thursday, October 29. Operating revenue rose to EUR 787.7 million, while normalized EBITDA reached EUR 129.9 million and normalized net profit stood at EUR 57.6 million.
Food and pharmaceuticals lead
The Food segment generated EUR 449.1 million in revenue. Sales of own brands increased 1.5 percent to EUR 408.1 million, supported by the Bakery business and the Cream Spreads and Confectionery category. Podravka said Lino Lada recorded strong growth in Germany, Poland and the Czech Republic.
Pharmaceuticals delivered EUR 140.8 million in revenue, up 8.8 percent from the comparable period. The non-prescription medicines programme grew 19.2 percent to EUR 22.5 million, making it a notable contributor to the group's expansion.
Agriculture remains the weak spot
Agriculture revenue declined 1.8 percent to EUR 204.3 million. Podravka linked the pressure to lower market prices for pigs, fattening cattle and raw milk, as well as adverse weather and drought that reduced yields for some arable crops. Improved operating efficiency and production processes partly offset those external pressures.
The company also reported self-sufficiency in pepper production for the first time, alongside strong wheat and barley yields. For investors, the results show a diversified earnings base: food and pharmaceuticals supported growth while agriculture remained exposed to commodity and weather conditions.
Podravka's business profile
Podravka is headquartered in Koprivnica, Croatia, and operates across Food, Agriculture and Pharmaceuticals. The group sells more than 1,900 products in over 60 markets and generates about two-thirds of its revenue internationally, according to its company profile. Its portfolio includes Vegeta, Lino, Dolcela, Fant, Cokolino, Kviki and Neofen.
Current market developments are covered in current market reports.
Podravka at a glance
- Company: Podravka d.d.
- Headquarters: Koprivnica, Croatia
- Reporting period: January to September 2026
- Operating revenue: EUR 787.7 million
- Normalized EBITDA: EUR 129.9 million
- Normalized net profit: EUR 57.6 million
- Business segments: Food, Agriculture and Pharmaceuticals
